Sabra Health Care REIT, Inc. (SBRA) wird mit einem nachlaufenden KGV von gehandelt 32.4, erwartetes KGV von 29.4. Die nachlaufende Gewinnrendite beträgt 3.09%, erwartete Gewinnrendite 3.40%. PEG 1.75. Die Graham-Zahl beträgt $12.61.
Durch diese Seite bewiesene Kriterien:
SharesGrow Gesamtbewertung: 56/100 mit 2/7 Kriterien bestanden.
| Year | P/E (TTM) | PEG-Verhältnis | P/B-Verhältnis | P/S-Verhältnis | Dividendenrendite |
|---|---|---|---|---|---|
| 2016 | 22.7 | -1.33 | 1.57 | 6.12 | 7.48% |
| 2017 | 12.5 | 0.24 | 0.58 | 4.89 | 9.18% |
| 2018 | 10.5 | 0.87 | 0.90 | 4.71 | 11.07% |
| 2019 | 57.9 | -0.76 | 1.14 | 5.98 | 8.40% |
| 2020 | 25.9 | 0.32 | 1.05 | 5.98 | 7.77% |
| 2021 | -26.2 | 0.15 | 0.88 | 5.21 | 8.86% |
| 2022 | -37.0 | 1.07 | 0.94 | 4.59 | 9.65% |
| 2023 | 239.8 | -2.04 | 1.18 | 5.10 | 8.41% |
| 2024 | 31.9 | 0.04 | 1.48 | 5.75 | 6.93% |
| 2025 | 29.4 | 1.59 | 1.62 | 5.90 | 6.33% |
| Year | EPS (verwässert) | Umsatz | Nettogewinn | Nettomarge |
|---|---|---|---|---|
| 2016 | $0.92 | $260.53M | $70.28M | 27% |
| 2017 | $1.40 | $405.65M | $158.38M | 39% |
| 2018 | $1.56 | $623.41M | $279.08M | 44.8% |
| 2019 | $0.37 | $661.74M | $69M | 10.4% |
| 2020 | $0.67 | $598.57M | $138.42M | 23.1% |
| 2021 | $-0.52 | $569.55M | $-113.26M | -19.9% |
| 2022 | $-0.34 | $624.81M | $-77.61M | -12.4% |
| 2023 | $0.06 | $647.51M | $13.76M | 2.1% |
| 2024 | $0.54 | $703.24M | $126.71M | 18% |
| 2025 | $0.64 | $774.63M | $155.61M | 20.1% |
| Year | EPS (Durchschn.) | EPS-Spanne | Umsatz (Durchschn.) | Umsatzspanne | Analysten |
|---|---|---|---|---|---|
| 2026 | $0.69 | $0.68 – $0.70 | $858.66M | $816.58M – $909.93M | 4 |
| 2027 | $0.77 | $0.76 – $0.80 | $929.45M | $883.9M – $984.95M | 4 |
| 2028 | $0.83 | $0.79 – $0.86 | $982.67M | $934.51M – $1.04B | 3 |
| 2029 | $0.84 | $0.79 – $0.91 | $1.09B | $1.04B – $1.16B | 1 |
| 2030 | $0.00 | $0.00 – $0.00 | $1.37B | $1.3B – $1.45B | 0 |
